Trials / Sponsors / Ocera Therapeutics, Inc.
Ocera Therapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | OCR002-SP103 - Oral Immediate Release Study Cirrhosis | Phase 1 | 2016-08-15 |
| Completed | Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalop Acute Episode of Overt Hepatic Encephalopathy, Hepatic Encephalopathy | Phase 2 | 2014-01-07 |
| No Longer Available | Emergency Use of OCR-002 in Acute Liver Failure (ALF) Acute Liver Failure | — | — |